Vik Van Duppen

441 total citations
6 papers, 355 citations indexed

About

Vik Van Duppen is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Vik Van Duppen has authored 6 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Molecular Biology, 2 papers in Oncology and 2 papers in Hematology. Recurrent topics in Vik Van Duppen's work include Acute Myeloid Leukemia Research (2 papers), Cancer Cells and Metastasis (2 papers) and Hematopoietic Stem Cell Transplantation (1 paper). Vik Van Duppen is often cited by papers focused on Acute Myeloid Leukemia Research (2 papers), Cancer Cells and Metastasis (2 papers) and Hematopoietic Stem Cell Transplantation (1 paper). Vik Van Duppen collaborates with scholars based in Belgium. Vik Van Duppen's co-authors include Hugo Vankelecom, Jianghai Chen, Nicole Hersmus, Carl Denef, Yingmei Feng, Catherine M. Verfaillie, Paul P. Van Veldhoven, Paul Holvoet, Sarah Schouteden and Paul Herijgers and has published in prestigious journals such as PLoS ONE, Endocrinology and Molecular Endocrinology.

In The Last Decade

Vik Van Duppen

6 papers receiving 352 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vik Van Duppen Belgium 4 180 164 67 65 49 6 355
Gail A. Stilling United States 11 321 1.8× 86 0.5× 146 2.2× 62 1.0× 79 1.6× 12 565
Sandy Laue Germany 12 191 1.1× 159 1.0× 94 1.4× 25 0.4× 65 1.3× 12 452
Maria-Beatriz S. Lopes United States 8 131 0.7× 148 0.9× 42 0.6× 106 1.6× 52 1.1× 8 412
Hiroki Ueharu Japan 13 264 1.5× 144 0.9× 85 1.3× 42 0.6× 69 1.4× 33 437
Noriyuki Tsukamoto Japan 9 356 2.0× 45 0.3× 94 1.4× 33 0.5× 37 0.8× 10 617
Luo-an Fu China 12 171 0.9× 127 0.8× 54 0.8× 86 1.3× 106 2.2× 18 427
Simona Wagner Canada 9 192 1.1× 51 0.3× 69 1.0× 16 0.2× 63 1.3× 10 352
Euvgeni Vlodavsky Israel 10 133 0.7× 36 0.2× 46 0.7× 55 0.8× 23 0.5× 14 348
Michelle Nguyen-McCarty United States 7 283 1.6× 30 0.2× 32 0.5× 59 0.9× 67 1.4× 8 398
Mauro Pomati Italy 9 201 1.1× 31 0.2× 105 1.6× 91 1.4× 79 1.6× 18 428

Countries citing papers authored by Vik Van Duppen

Since Specialization
Citations

This map shows the geographic impact of Vik Van Duppen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vik Van Duppen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vik Van Duppen more than expected).

Fields of papers citing papers by Vik Van Duppen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vik Van Duppen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vik Van Duppen. The network helps show where Vik Van Duppen may publish in the future.

Co-authorship network of co-authors of Vik Van Duppen

This figure shows the co-authorship network connecting the top 25 collaborators of Vik Van Duppen. A scholar is included among the top collaborators of Vik Van Duppen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vik Van Duppen. Vik Van Duppen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Feng, Yingmei, Sarah Schouteden, Vik Van Duppen, et al.. (2012). Hematopoietic Stem/Progenitor Cell Proliferation and Differentiation Is Differentially Regulated by High-Density and Low-Density Lipoproteins in Mice. PLoS ONE. 7(11). e47286–e47286. 68 indexed citations
2.
Gremeaux, Lies, Qiuli Fu, Vik Van Duppen, et al.. (2009). Cancer stem cells in human pituitary adenoma: identification and characterization of a tumor ‘side population’. 2 indexed citations
3.
Gremeaux, Lies, Jianghai Chen, Gregory Sergeant, et al.. (2008). In search of cancer stem cells in primary human tumors: a “side population” is present in both benign and malignant neoplasms. 1 indexed citations
4.
Chen, Jianghai, et al.. (2006). The Notch Signaling System Is Present in the Postnatal Pituitary: Marked Expression and Regulatory Activity in the Newly Discovered Side Population. Molecular Endocrinology. 20(12). 3293–3307. 65 indexed citations
5.
Chen, Jianghai, et al.. (2005). The Adult Pituitary Contains a Cell Population Displaying Stem/Progenitor Cell and Early Embryonic Characteristics. Endocrinology. 146(9). 3985–3998. 199 indexed citations
6.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gail A. Stilling Breakdown of academic impact, for papers by Sandy Laue Breakdown of academic impact, for papers by Maria-Beatriz S. Lopes Breakdown of academic impact, for papers by Hiroki Ueharu Breakdown of academic impact, for papers by Noriyuki Tsukamoto Breakdown of academic impact, for papers by Luo-an Fu Breakdown of academic impact, for papers by Simona Wagner Breakdown of academic impact, for papers by Euvgeni Vlodavsky Breakdown of academic impact, for papers by Michelle Nguyen-McCarty Breakdown of academic impact, for papers by Mauro Pomati
Rankless by CCL
2026